Development and validation of a predictive model to guide the use of plerixafor in pediatric population

Bernard Sebastien, Peter Cheverton, Catherine Magnin, Jihane Aouni, Remi Castan

Open source

DOI
10.1038/s41409-022-01831-2
Published
2022-09-26
Container
Bone Marrow Transplantation
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41409-022-01831-2,
  title = {Development and validation of a predictive model to guide the use of plerixafor in pediatric population},
  author = {Bernard Sebastien and Peter Cheverton and Catherine Magnin and Jihane Aouni and Remi Castan},
  year = {2022},
  journal = {Bone Marrow Transplantation},
  doi = {10.1038/s41409-022-01831-2},
  url = {https://doi.org/10.1038/s41409-022-01831-2}
}

RIS

TY  - JOUR
TI  - Development and validation of a predictive model to guide the use of plerixafor in pediatric population
AU  - Bernard Sebastien
AU  - Peter Cheverton
AU  - Catherine Magnin
AU  - Jihane Aouni
AU  - Remi Castan
PY  - 2022
JO  - Bone Marrow Transplantation
DO  - 10.1038/s41409-022-01831-2
UR  - https://doi.org/10.1038/s41409-022-01831-2
ER  - 

APA

Sebastien, B., Cheverton, P., Magnin, C., Aouni, J., & Castan, R. (2022). Development and validation of a predictive model to guide the use of plerixafor in pediatric population. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-022-01831-2

Source records